Krishnansu S. Tewari

Papers

Total Citations

H-Index

About

Dr. Krishnansu S. Tewari is a pioneering gynecologic oncologist whose research has fundamentally shaped the surgical management of gynecologic cancers. His primary focus lies in advancing minimally invasive surgery, particularly robotic-assisted techniques, for conditions like cervical and endometrial cancers. Dr. Tewari is best known for his leadership in the landmark ROCC/GOG-3043 trial, a randomized non-inferiority study comparing robotic versus open radical hysterectomy for early-stage cervical cancer. This work directly challenges the controversial findings of the 2018 LACC trial, which questioned the safety of minimally invasive surgery, and his contributions are critical in redefining surgical standards. His highly cited 2020 review on robotic surgery for gynecologic cancers (25 citations) has become a key reference for surgeons, detailing indications, techniques, and controversies. Additionally, Dr. Tewari has explored oncofertility in advanced cervical cancer, as demonstrated in a 2018 case report on robotic radical trachelectomy. With over 20,000 citations across his career, his work continues to influence clinical practice, balancing oncologic safety with improved patient recovery and quality of life.